Effect of Fampridine-PR (prolonged released 4-aminopyridine) on the manual functions of patients with Multiple Sclerosis

Journal of the Neurological Sciences

Volumn 360, Issue , 2016, Pages 102-109

  Savin, Ziv ^a   Lejbkowicz, Izabella ^a,b   Glass Marmor, Lea ^a,b   Lavi, Idit ^b   Rosenblum, Sara ^c   Miller, Ariel ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

Author keywords

Fampridine PR; Hands function; Handwriting; International classification of functioning; Multiple sclerosis; Neurorehabilitation

Indexed keywords

FAMPRIDINE; DELAYED RELEASE FORMULATION; POTASSIUM CHANNEL BLOCKING AGENT;

9 HOLE PEG TEST; ABILHAND QUESTIONNAIRE; ACTIVITY OF DAILY LIVING ASSESSMENT; ADULT; AGED; ARTHRITIS HAND FUNCTION TEST; ARTICLE; CLINICAL ARTICLE; COMPUTERIZED PENMANSHIP EVALUATION TOOL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HAND GRIP; HUMAN; MALE; MOBILIZATION; MULTIPLE SCLEROSIS; MUSCULOSKELETAL DISEASE ASSESSMENT; PINCH STRENGTH; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT DURATION; ADMINISTRATION AND DOSAGE; DAILY LIFE ACTIVITY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; GAIT; HAND STRENGTH; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; THERAPEUTIC USE; TREATMENT OUTCOME; WALKING;

4-AMINOPYRIDINE; ACTIVITIES OF DAILY LIVING; ADULT; DELAYED-ACTION PREPARATIONS; FEMALE; GAIT; HAND STRENGTH; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POTASSIUM CHANNEL BLOCKERS; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; WALKING;

EID: 84955468452     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2015.11.035     Document Type: Article

References (39)

1. L. Holper, M. Coenen, A. Weise, G. Stucki, A. Cieza, and J. Kesselring Characterization of functioning in multiple sclerosis using the ICF J. Neurol. 257 1 2010 103 113 10.1007/s00415-009-5282-4
2. S. Johansson, C. Ytterberg, I.M. Claesson, J. Lindberg, J. Hillert, M. Andersson, L. Widen Holmqvist, and L. von Koch High concurrent presence of disability in multiple sclerosis. Associations with perceived health J. Neurol. 254 6 2007 767 773 10.1007/s00415-006-0431-5
3. M. Kierkegaard, U. Einarsson, K. Gottberg, L. von Koch, and L.W. Holmqvist The relationship between walking, manual dexterity, cognition and activity/participation in persons with multiple sclerosis Mult. Scler. 18 5 2012 639 646 10.1177/1352458511426736 1352458511426736 [pii]
4. N. Yozbatiran, F. Baskurt, Z. Baskurt, S. Ozakbas, and E. Idiman Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients J. Neurol. Sci. 246 1-2 2006 117 122 10.1016/j.jns.2006.02.018 (S0022-510X(06)00081-5 [pii])
5. M.W. Koch, T.J. Murray, J. Fisk, J. Greenfield, V. Bhan, P. Jacobs, M. Brown, and L.M. Metz Hand dexterity and direct disease related cost in multiple sclerosis J. Neurol. Sci. 341 1-2 2014 51 54 10.1016/j.jns.2014.03.047 S0022-510X(14)00208-1 [pii]
6. D. Gijbels, I. Lamers, L. Kerkhofs, G. Alders, E. Knippenberg, and P. Feys The Armeo Spring as training tool to improve upper limb functionality in multiple sclerosis: a pilot study J. Neuroeng. Rehabil. 8 2011 5 10.1186/1743-0003-8-5
7. L. Bonzano, A. Tacchino, G. Brichetto, L. Roccatagliata, A. Dessypris, P. Feraco, M.L. Lopes De Carvalho, M.A. Battaglia, G.L. Mancardi, and M. Bove Upper limb motor rehabilitation impacts white matter microstructure in multiple sclerosis NeuroImage 90 2014 107 116 10.1016/j.neuroimage.2013.12.025
8. A. Kalron, M. Greenberg-Abrahami, S. Gelav, and A. Achiron Effects of a new sensory re-education training tool on hand sensibility and manual dexterity in people with multiple sclerosis NeuroRehabilitation 32 4 2013 943 948 10.3233/nre-130917
9. I. Lamers, and P. Feys Assessing upper limb function in multiple sclerosis Mult. Scler. 2014 10.1177/1352458514525677
10. C.P. Kamm, H.P. Mattle, R.M. Muri, M.R. Heldner, V. Blatter, S. Bartlome, J. Luthy, D. Imboden, G. Pedrazzini, S. Bohlhalter, R. Hilfiker, and T. Vanbellingen Home-based training to improve manual dexterity in patients with multiple sclerosis: a randomized controlled trial Mult. Scler. 2015 10.1177/1352458514565959
11. R. Gatti, A. Tettamanti, S. Lambiase, P. Rossi, and M. Comola Improving hand functional use in subjects with multiple sclerosis using a musical keyboard: a randomized controlled trial Physiother. Res. Int. 20 2 2015 100 107 10.1002/pri.1600
12. A.I. Spooren, A.A. Timmermans, and H.A. Seelen Motor training programs of arm and hand in patients with MS according to different levels of the ICF: a systematic review BMC Neurol. 12 2012 49 10.1186/1471-2377-12-49
13. A.D. Goodman, T.R. Brown, L.B. Krupp, R.T. Schapiro, S.R. Schwid, R. Cohen, L.N. Marinucci, and A.R. Blight Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial Lancet 373 9665 2009 732 738 10.1016/S0140-6736(09)60442-6 S0140-6736(09)60442-6 [pii]
14. S.R. Schwid, A.D. Goodman, D.H. Mattson, C. Mihai, K.M. Donohoe, M.D. Petrie, E.A. Scheid, J.T. Dudman, and M.P. McDermott The measurement of ambulatory impairment in multiple sclerosis Neurology 49 5 1997 1419 1424
15. Solari A, Uitdehaag B, Giuliani G, Pucci E, Taus C (2001) Aminopyridines for symptomatic treatment in multiple sclerosis. Cochrane Database Syst. Rev. (4):CD001330. doi:CD001330 [pii] http://dx.doi.org/10.1002/14651858.CD001330.
16. H.A. van Diemen, C.H. Polman, T.M. van Dongen, A.C. van Loenen, J.J. Nauta, M.J. Taphoorn, H.K. van Walbeek, and J.C. Koetsier The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study Ann. Neurol. 32 2 1992 123 130 10.1002/ana.410320203
17. R. Schniepp, V. Jakl, M. Wuehr, J. Havla, T. Kumpfel, M. Dieterich, M. Strupp, and K. Jahn Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report Mult. Scler. 19 4 2013 506 508 10.1177/1352458512461394 1352458512461394 [pii]
18. H. Jensen, M. Ravnborg, S. Mamoei, U. Dalgas, and E. Stenager Changes in cognition, arm function and lower body function after slow-release fampridine treatment Mult. Scler. 20 14 2014 1872 1880 10.1177/1352458514533844
19. E. Allart, A. Benoit, A. Blanchard-Dauphin, V. Tiffreau, A. Thevenon, H. Zephir, O. Outteryck, A. Lacour, and P. Vermersch Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life J. Neurol. 2015 10.1007/s00415-015-7797-1
20. I. Lamers, S. Kelchtermans, I. Baert, and P. Feys Upper limb assessment in multiple sclerosis: a systematic review of outcome measures and their psychometric properties Arch. Phys. Med. Rehabil. 95 6 2014 1184 1200 10.1016/j.apmr.2014.02.023 S0003-9993(14)00185-3 [pii]
21. C. Savva, G. Giakas, M. Efstathiou, and C. Karagiannis Test-retest reliability of handgrip strength measurement using a hydraulic hand dynamometer in patients with cervical radiculopathy J. Manip. Physiol. Ther. 37 3 2014 206 210 10.1016/j.jmpt.2014.02.001 S0161-4754(14)00035-9 [pii]
22. Chen CC, Kasven N, Karpatkin HI, Sylvester A (2007) Hand strength and perceived manual ability among patients with multiple sclerosis. Arch. Phys. Med. Rehabil. 88 (6):794-797. doi:S0003-9993(07)00219-5 [pii] http://dx.doi.org/10.1016/j.apmr.2007.03.010.
23. A. Guclu-Gunduz, S. Citaker, B. Nazliel, and C. Irkec Upper extremity function and its relation with hand sensation and upper extremity strength in patients with multiple sclerosis NeuroRehabilitation 30 4 2012 369 374 10.3233/NRE-2012-0768 N331716367711231 [pii]
24. V. Mathiowetz, G. Volland, N. Kashman, and K. Weber Adult norms for the Box and Block Test of manual dexterity Am. J. Occup. Ther. 39 6 1985 386 391
25. C. Backman, and H. Mackie Arthritis hand function test: inter-rater reliability among self-trained raters Arthritis Care Res. 8 1 1995 10 15
26. J.L. Poole, M. Gallegos, and S. O'Linc Reliability and validity of the Arthritis Hand Function Test in adults with systemic sclerosis (scleroderma) Arthritis Care Res. 13 2 2000 69 73
27. L.M. Brower, and J.L. Poole Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma) Arthritis Rheum. 51 5 2004 805 809 10.1002/art.20701
28. M. Penta, J.L. Thonnard, and L. Tesio ABILHAND: a Rasch-built measure of manual ability Arch. Phys. Med. Rehabil. 79 9 1998 1038 1042 doi:S0003-9993(98)90167-8 [pii]
29. L.E. Barrett, S.J. Cano, J.P. Zajicek, and J.C. Hobart Can the ABILHAND handle manual ability in MS? Mult. Scler. 19 6 2013 806 815 10.1177/1352458512462919 1352458512462919 [pii]
30. A. Simone, V. Rota, L. Tesio, and L. Perucca Generic ABILHAND questionnaire can measure manual ability across a variety of motor impairments Int. J. Rehabil. Res. 34 2 2011 131 140 10.1097/MRR.0b013e328343d4d3
31. S. Rosenblum, S. Parush, and P.L. Weiss Computerized temporal handwriting characteristics of proficient and non-proficient handwriters Am. J. Occup. Ther. 57 2 2003 129 138
32. S. Rosenblum, and P.L. Tamar Weiss Evaluating functional decline in patients with multiple sclerosis Res. Dev. Disabil. 31 2 2010 577 586 10.1016/j.ridd.2009.12.008 S0891-4222(09)00204-2 [pii]
33. Werner P, Rosenblum S, Bar-On G, Heinik J, Korczyn A (2006). Handwriting process variables discriminating mild Alzheimer's disease and mild cognitive impairment. J. Gerontol. B Psychol. Sci. Soc. Sci. 61 (4):P228-236. doi:61/4/P228 [pii].
34. S. Rosenblum, S. Parush, and P.L. Weiss The in air phenomenon: temporal and spatial correlates of the handwriting process Percept. Mot. Skills 96 3 Pt 1 2003 933 954 10.2466/pms.2003.96.3.933
35. J.J. Kragt, F.A. van der Linden, J.M. Nielsen, B.M. Uitdehaag, and C.H. Polman Clinical impact of 20% worsening on timed 25-foot walk and 9-hole peg test in multiple sclerosis Mult. Scler. 12 5 2006 594 598
36. J.C. Hobart, A. Riazi, D.L. Lamping, R. Fitzpatrick, and A.J. Thompson Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12) Neurology 60 1 2003 31 36
37. L.V. Bosma, J.J. Kragt, L. Brieva, Z. Khaleeli, X. Montalban, C.H. Polman, A.J. Thompson, M. Tintore, and B.M. Uitdehaag Progression on the multiple sclerosis functional composite in multiple sclerosis: what is the optimal cut-off for the three components? Mult. Scler. 16 7 2010 862 867 10.1177/1352458510370464
38. M. Prugger, and T. Berger Assessing the long-term clinical benefit of prolonged-release fampridine tablets in a real-world setting: a review of 67 cases Patient Relat. Outcome Meas. 4 2013 75 85 10.2147/prom.s42957
39. R. Rudick, J. Antel, C. Confavreux, G. Cutter, G. Ellison, J. Fischer, F. Lublin, A. Miller, J. Petkau, S. Rao, S. Reingold, K. Syndulko, A. Thompson, J. Wallenberg, B. Weinshenker, and E. Willoughby Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force Ann. Neurol. 42 3 1997 379 382 10.1002/ana.410420318